Efavirenz levels and 24-week efficacy in HIV-infected patients with tuberculosis receiving highly active antiretroviral therapy and rifampicin (Q44562799)
Jump to navigation
Jump to search
scientific article published in September 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efavirenz levels and 24-week efficacy in HIV-infected patients with tuberculosis receiving highly active antiretroviral therapy and rifampicin |
scientific article published in September 2005 |
Statements
1 reference
Efavirenz levels and 24-week efficacy in HIV-infected patients with tuberculosis receiving highly active antiretroviral therapy and rifampicin (English)
1 reference
Kiat Ruxrungtham
1 reference
Sasisopin Kiertiburanakul
1 reference
Somnuek Sungkanuparph
1 reference
Ammarin Thakkinstian
1 reference
Weerawat Manosuthi
1 reference
Asda Vibhagool
1 reference
Sasivimol Rattanasiri
1 reference
Wisit Prasithsirikul
1 reference
Jongkol Sankote
1 reference
Apicha Mahanontharit
1 reference
1 September 2005
1 reference
Identifiers
1 reference